Stocks and InvestingStocks and Investing
Wed, October 27, 2021
Tue, October 26, 2021
Mon, October 25, 2021
Sun, October 24, 2021
Fri, October 22, 2021

Emmanuel Papadakis Initiated (BNTX) at Hold and Held Target at $250 on, Oct 22nd, 2021


Published on 2024-10-27 18:17:30 - WOPRAI, Emmanuel Papadakis
  Print publication without navigation


Emmanuel Papadakis of Deutsche Bank, Initiated "BioNTech SE" (BNTX) at Hold and Held Target at $250 on, Oct 22nd, 2021.

Emmanuel has made no other calls on BNTX in the last 4 months.



There are 6 other peers that have a rating on BNTX. Out of the 6 peers that are also analyzing BNTX, 4 agree with Emmanuel's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Akash Tewari of "Jefferies" Initiated at Hold and Held Target at $230 on, Thursday, October 7th, 2021
  • Daina Graybosch of "SVB Leerink" Maintained at Hold with Decreased Target to $268 on, Tuesday, October 5th, 2021
  • Eliana Merle of "UBS" Maintained at Hold with Increased Target to $300 on, Friday, August 27th, 2021
  • Robert Burns of "HC Wainwright & Co." Maintained at Hold with Increased Target to $330 on, Wednesday, August 11th, 2021


These are the ratings of the 2 analyists that currently disagree with Emmanuel


  • Arlinda Lee of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $450 on, Friday, August 20th, 2021
  • Olga Smolentseva of "Bryan Garnier" Upgraded from Hold to Strong Buy and Held Target at $451 on, Wednesday, August 11th, 2021